AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
AstraZeneca(AZN) stock is priced at $187.75, giving the company a market capitalization of 292.19B. It carries a P/E multiple of 28.11 and pays a dividend yield of 1.67%.
On 2026-06-29, AstraZeneca(AZN) stock traded between a low of $183.81 and a high of $189.57. Shares are currently priced at $187.75, which is +2.1% above the low and -1.0% below the high.
AstraZeneca(AZN) shares are trading with a volume of 3.19M, against a daily average of 1.96M.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $137.23.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $137.23.
AZN News
Enhertu has been approved in the European Union, or EU, as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive solid...
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
...
Analyst ratings
83%
of 29 ratingsMore AZN News
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium fo...
Astrazeneca (AZN) closed at $96.34 in the latest trading session, marking a +1.94% move from the prior day. The stock outperformed the S&P 500, which registered...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium fo...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium fo...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for mor...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium fo...
Analyst Sarita Kapila of Morgan Stanley maintained a Buy rating on AstraZeneca, retaining the price target of p16,500.00. Unlock powerful investing tools and d...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.